Phase 1a Study in Healthy Smokers to Investigate the Effect With MMI-0100 on Airway Inflammation in Induced Sputum After Challenge With Inhaled Lipopolysaccharide
PHASE1UnknownINTERVENTIONAL
Enrollment
20
Participants
Timeline
Start Date
July 31, 2015
Primary Completion Date
March 31, 2016
Study Completion Date
June 30, 2017
Conditions
Acute Inflammatory Response to Non-antigenic Stimulus
Interventions
DRUG
MMI-0100
DRUG
Placebo
Trial Locations (1)
W1G 8HU
Respiratory Clinical Trials, The Heart Lung Centre, London